zDHHC4 is involved in mediating the palmitoylation of GSK3β, which contributes to the promotion of tumorigenicity in temozolomide-resistant glioblastoma stem cells. This effect is achieved through the EZH2-STAT3 axis. The gene discussed is STAT3; the disease is glioblastoma.